Skip to main content
Download PDF

Protoscolicidal effects of curcumin nanoemulsion against protoscoleces of Echinococcus granulosus

BMC Complementary Medicine and Therapies volume 23, Article number: 124 (2023) Cite this article

Abstract

Background

The aim of the present study was to assess in vitro protoscolicidal effects of curcumin nanoemulsion (CUR-NE) against protoscoleces of cystic echinococcosis (CE)/hydatid cysts.

Methods

The CUR-NE was prepared via spontaneous emulsification of soybean as the oil phase, a mixture of Tween 80 and Tween 85 as the surfactant, ethanol as the co-surfactant and distilled water. Various concentrations of CUR-NE (156, 312, 625 and 1250 µg/ml) were exposed to collected protoscoleces of infected sheep liver hydatid cysts for 10, 20, 30, 60 and 120 min. Viability of the protoscoleces were assessed using eosin exclusion test. Morphological changes of the protoscoleces were observed using differential interference contrast (DIC) microscopy.

Results

The mean particle size and zeta potential of CUR-NE included 60.4 ± 14.8 nm and − 16.1 ± 1.1 mV, respectively. Results showed that the viability of the protoscoleces decreased significantly with increases in CUR-NE concentrations (p < 0.001). The mortality rates of protoscoleces with exposure to concentrations of 1250 and 625 µg/ml of CUR-NE for 60 min were 94 and 73.33%, respectively. Mortality of the protoscoleces was 100% after 120 min of exposure to 1250 and 625 µg/ml concentrations of CUR-NE. Using NIC microscopy, extensively altered tegumental surface protoscoleces was observed after protoscoleces exposure to CUR-NE.

Conclusion

The findings of the present study revealed the in vitro protoscolicidal potential of CUR-NE. Therefore, CUR-NEs are addressed as novel protoscolicidal agents, which can be used as an alternative natural medicine to kill the protoscoleces, owing to their low toxicity and significant inhibition potency. However, further studies are necessary to investigate pharmacologic and pharmacokinetics of CUR-NEs.

Peer Review reports

Introduction

Cystic echinococcosis (CE)/hydatidosis is a cosmopolitan zoonotic tapeworm disease with various clinical complications in humans and herbivores. It is caused by the larval stage of Echinococcus granulosus sensu lato [1]. Based on the World Health Organization (WHO) reports, CE is one of the 17 neglected tropical diseases (NTDs) with an important challenge from medical and economic points of view [2]. The CE causative agents are mostly transmitted between the canines (primary definitive hosts) and various livestock species (intermediate hosts). Human and other intermediate hosts become infected through accidental direct ingestion of the infective eggs of E. granulosus sensu lato as well as contaminated water and/or foods [3,4,5,6]. The disease usually develops in the host liver and lungs with less rate in other organs, including brain and bones of the intermediate hosts [1]. Clinical characteristics of CE depend on various factors, including involved organs, locations, numbers and sizes of cysts in the involved organs as well as mass effects within the organs and the surrounding structures [5]. Currently, various single or combined options for the treatment of CE are available, including surgery, percutaneous methods [puncture, aspiration, injection and re-aspiration (PAIR)] and chemotherapy with benzimidazole derivatives (mebendazole and albendazole) for live cysts, as well as “watch and wait” method for the silent cysts based on image classifications following stage-specific approaches [7]. Toxic side effects with high frequencies are the major limitations of chemical drugs. The frequent side effects are alopecia, hepatotoxicity, leucopenia, osteoporosis, teratogenicity and thrombocytopenia [8,9,10,11]. Additionally, the most important complications of surgery and PAIR for the treatment of CE include possible ruptures of the cysts or leakage of the cyst protoscoleces contents that can be lead to anaphylactic shock, secondary infections, and even death of the patients [12, 13]. To solve these problems, before surgery, the surgeons usually use a broad spectrum of protoscolicidal agents such as 20% hypertonic saline, silver nitrate and cetrimide to decrease risks of spillage of viable protoscoleces and possible recurrence episodes [5]. However, serious complications such as biliary fibrosis, hepatic necrosis, and cirrhosis have limited use of these agents [5]. Therefore, the use of novel protoscolicidal substances for intraoperative killing of protoscoleces with high efficacy and low side effects are necessary during surgery.

Curcumin (CUR) [1,7-bis(4-hydroxy-3-ethoxyphenyl)-1,6-heptadien-3,5-dione] is a natural phenolic compound extracted from the ground rhizomes of a perennial herb, Curcuma longa Linnaeus. Pharmacological safety and efficacy of CUR make it a potential compound for the treatment and prevention of various diseases such as chronic diseases, allergies, arthritis, wounds, metal-induced liver damage, diabetes, migraine, Alzheimer’s disease and neurological disorders [14,15,16,17,18,19]. In addition to its harmless nature, investigations on pharmacological properties of CUR have shown extensive ranges of promising biological and pharmacological activities, including anti-microbial [20], anti-inflammatory [21], anti-osteoarthritis [22] and anticarcinogenic properties [23]. Furthermore, cytotoxic and parasiticidal issues of CUR have been demonstrated in helminthic parasites such as Schistosoma mansoni, S. japonicum [24] and a wide range of protozoan parasites such as Leishmania spp. [25, 26], Giardia lamblia [27], Trypanosoma [28, 29], Plasmodium falciparum [30] and Toxoplasma gondii [31]. Morover, the in vitro efficacy of chitosan-curcumin [32] and chitosan nanoparticles (NPs) [33] have been evaluated against protoscoleces of E. granulosus.

Despite numerous advantages of CUR, hydrophobic nature of the CUR derivatives, low aqueous solubility, chemical instability, poor bioavailability, short half-life and rapid metabolism create serious challenges to its effectiveness [34]. In recent years, nanotechnology has been introduced to medical societies as an advanced technology for addressing these limitations [34]. Since it can increase the solubility and cellular uptake efficiency, dissolution, and bioavailability of materials at the desired site of action and, consequently, improve the therapeutic effectiveness [35, 36]. Moreover, the nanomaterials can improve cell penetration and also maintain effective intracellular delivery and accumulation [35]. Various kinds of formulations have been used to tackle this issue. From these formulations, nanoemulsion (NE) has been technologically advanced to improve CUR solubility and bioavailability [35]. These NEs or fine oil-in-water dispersions stabilized with small quantities of emulsifiers are very small and hence cannot scatter the light beams. Thus, NEs seem clear despite their opaque appearance [37]. Despite the studies on natural products such as Curcuma extracts and its derivatives against protoscoleces of CE [38,39,40], no study has been carried out on the effects of curcumin nanoemulsion (CUR-NE) on protoscoleces of CE, so far. Therefore, the aim of this study is in vitro assessment of the protoscolicidal efficacy of CUR-NE against protoscoleces of CE.

Materials and methods

Compounds

CUR (CAS-No:458-37-7; Sigma-Aldrich; Purity: ≥80%), Soybean oil and eosin powder (Sigma-Aldrich) were used for the study. In addition, sodium chloride, ethanol, methanol and polysorbates of Tween 80 and Tween 85 (Merck, Germany) were also used in this work.

Preparation of curcumin nanoemulsion

The CUR-NE was successfully prepared as described previously by the authors using spontaneous emulsification of soybean as the oil phase, a mixture of Tween 80 and Tween 85 as the surfactant, ethanol as the co-surfactant and distilled water. Prepared CUR-NE was characterized using Malvern Zetasizer Nano ZS instrument and transmission electron microscopy [31].

Protoscoleces collection

Protoscoleces of E. granulosus sensu stricto were collected from livers of the naturally infected sheep, slaughtered at Shiraz slaughterhouse, Fars Province, Southern Iran. Protocols for the preparation of protoscoleces and viability assessment were previously described by Sadjjadi et al. [41].

In vitro protoscolicidal activity

In the current study, a concentration of 1250 µg/ml of CUR-NE was prepared, solution then being a 1/2 dilution in the series. Various concentrations of CUR-NE, including 1250, 625, 312 and 156 µg/ml, were used for various exposure times, including 10, 20, 30, 60 and 120 min. Initially, 0.5 ml of the protoscoleces (2 × 103/ml) solution was transferred into test tubes. Then, 0.5 ml of various CUR-NE concentrations were added to each test tube and mixed well. Test tubes were incubated at 37 °C for 10, 20, 30, 60 and 120 min. Then, the upper phase of the mixture was removed carefully and 25 µl of eosin stain (0.1%) was added to the pellet of protoscoleces and gently mixed. Protoscoleces sediment were smeared on glass slides. Using light microscopy the viability protoscoleces were measured [42]. Phosphate buffered saline (PBS) solutions containing Tween 80 (10%) as surfactant in the preparation of CUR-NE was used as negative control. A solution of 20% hypertonic saline was also used as positive control. Experiments were carried out in triplicate and the mean and standard deviation (SD) were calculated for the samples.

Viability assay

The viability of the protoscoleces was evaluated by their flame cell motility under light microscope as well as impermeability to 0.1% eosin solution. Technically, dead protoscoleces absorb eosin and become red and live protoscoleces do not absorb eosin (no color), demonstrating typical muscular movements and flame cell activity (Fig. 1). Moreover, mortality rate of the protoscoleces was calculated and reported as the proportion of dead protoscoleces to total protoscoleces [43].

Fig. 1
figure 1

Dead (A) and live (B) protoscoleces after staining with 0.1% eosin

Full size image

Assessment of the morphologic structure of protoscoleces using differential interference contrast (DIC)/Nomarski microscopy

The morphological changes of protoscoleces including calcareous corpuscles structure changes, disorganization of the hooks and destruction of tegument were carefully observed in control and treated (CUR-NEs) groups using DIC/Nomarski microscopy.

Statistical analysis

Statistical analysis was conducted using GraphPad Prism Software v.8.0.0 for Windows (GraphPad, USA). Statistical differences between the treatment and control groups were reported using one-way analysis of variance (ANOVA) with 95% confidence intervals (CI) followed by Games-Howell multiple comparisons test [44]. Results were recorded as mean ± SD and p-values < 0.05 were reported as significant.

Results

Characterization of curcumin nanoemulsion

In this study, CUR-NEs were successfully synthesized. The mean particle size of CUR-NEs by DLS was 60.4 ± 14.8 nm and their zeta potential was − 16.1 ± 1.1 mV. The spherical shape and size of the CUR-NEs were verified using TEM (Fig. 2).

Fig. 2
figure 2

Transmission electron micrograph of the curcumin nanoemulsion

Full size image

In vitro experiments

In the present study, the viable protoscoleces upper than 90% were used for further experiments. Viable protoscoleces remain colorless and show amoeboid like movement and flame cell activity under light microscope. Simultaneously, non-viable protoscoleces get colored by eosin staining. Figure 3 shows in vitro protoscolicidal activity of various CUR-NE concentrations (156, 312, 625 and 1250 µg/ml) with various exposure times (10, 20, 30, 60 and 120 min) against protoscoleces of CE. Statistically, differences between the protoscolicidal effects of CUR-NEs were significant for all concentrations and exposure times, compared with the negative control (p < 0.001). Results showed that viability of the protoscoleces decreased significantly with increases in CUR-NE concentrations (p < 0.001). At concentrations of 1250 and 625 µg/ml for 60 min, mortality rates were measured as 94% and 73.33%, respectively. A 100% mortality rate was observed at 1250 and 625 µg/ml concentrations of CUR-NEe after 120 min. The minimum protoscolicidal activity of CUR-NEs included 11.67% (156 µg/ml, 10 min). ANOVA analysis demonstrated statistically significant differences between the mean rates of protoscoleces mortality in treatment groups at various exposure times, compared with the negative control (p < 0.001).

Fig. 3
figure 3

In vitro protoscolicidal effects of curcumin nanoemulsion against protoscoleces of Echinococcus granulosus sensu stricto at various concentrations and exposure times. Positive control, 20% hypertonic saline; negative control, phosphate buffered saline containing Tween 80

Full size image

Morphological and structural analyses of treated protoscoleces of CE

Normal morphology was observed in untreated (control) protoscoleces of CE with intact, stable tegument uniformed within the entire cell perimeter and obvious calcareous corpuscles as well as normal arrangement of hooks on the rostellum (Fig. 4A, C, E and G). In contrast, the treated protoscoleces showed loss of viability, and morphological changes such as severe damage to the tegument, reduction in the size and number of the calcareous corpuscles and disorganization of rostellar hooks (Fig. 4B, D, F and H).

Fig. 4
figure 4

A, C, E and G, micrographs of the hydatid cyst protoscoleces of the control group, showing intact, stable tegument uniformed within the entire cell perimeter as well as obvious calcareous corpuscles and normal arrangement of hooks on the rostellum; B, D, F and H, micrographs of the hydatid cyst protoscoleces in groups treated with 1250 µg/ml of CUR-NEs, showing thin and tear tegument (3 H), faded calcareous corpuscles and disorganization of rostellar hooks, Notes: red arrow in B, D, and F micrographs points at hooks

Full size image

Discussion

Natural medicines have been used for different parasitic diseases for centuries. Due to the good biodegradability and safe nature for the host organs, traditional and natural medicines have been studied extensively for drug discoveries in recent decades [45,46,47,48]. Nowadays, several available drugs originate from herbal sources and some of the effective drugs are naturally based [49]. CUR is a natural, nontoxic polyphenolic phytochemical, which has been used for several centuries as a therapeutic and health-promoting agent [20]. After the first scientific report by Oppenheimer (1937) on the use of CUR in human biliary disease [50], interests in studies on CUR have increased dramatically. Safety, tolerability and nontoxicity of CUR are well-verified in animals and humans even at high doses [51,52,53,54]. CUR and its derivatives have extensively been popular due to their anti-inflammatory [21, 53] and anti-microbial effects [55, 56]. Up-to-date studies have been carried out to assess effects of Curcuma extract and its derivatives against protoscoleces of CE [38, 40]. More recently, efficacy of C. longa essential oil (CLEO) against protoscoleces of CE was assessed and demonstrated that protoscoleces were completely killed after 5 and 10 min of exposure to doses of 200 and 100 µl /ml CLEO, respectively [40]. Similar studies showed that ethanolic extract of C. longa includes antiparasitic effects against protoscoleces of CE and the mortality rates of protoscoleces following exposure to C. longa extract at 50 mg/ml were 71.0, 81.3 and 93.2% after 10, 20 and 30 min, respectively [38].

Similar to the natural form of CUR, its nanoform is able to prevent and eliminate the growth of various microbes such as bacteria, fungi and parasites. The present study showed protoscolicidal effects of CUR-NE against protoscoleces of CE. Results demonstrated that viability of protoscoleces decreased significantly with increases in all concentrations of CUR-NEs (p < 0.001). The current findings showed that CUR-NEs included potent protoscolicidal activities, especially after 120 min at 1250 and 625 µg/ml (100% mortality rate). Similarly, Azami et al. (2018) showed potential of CUR-NEs in treatment of acute and chronic toxoplasmosis in mouse models [31]. Naturally, NEs provide larger surfaces, including potency of increased solubility. This potency is mostly due to the large interfacial adsorption of the core compounds, increased bioavailability due to the fast delivery of the active compounds to plasma membranes (PM) and organized releases of the drugs [57]. Furthermore, NPs such as silver, chitosan and CUR have been used for the treatment of giardiasis in experimental animal models, and results showed that the number of the parasites in stool and small intestinal sectors decreased in treated rats, compared with non-treated ones [58]. In a recent study, mortality rates of protoscoleces respectively included 28 and 32% after 60 min of exposure to 4 mg/ml chitosan and CUR, while the mortality rate was nearly 68% in the presence of chitosan NPs containing CUR (Ch-Cu NPs) at a same concentration after 60 min [59]. Although, pharmacological mechanisms of CUR are possibly associated with the compound inhibition of various biological cell signaling pathways and enzymes, the exact molecular mechanisms of CUR parasiticidal activity need further investigations [59].

In recent years, multiple inorganic NPs have been assessed against protoscoleces of CE [59, 60]. Mahmoudvand et al. (2014) showed that biogenic selenium NPs (Se-NPs) at all concentrations have potential protoscolicidal effects against protoscoleces of CE [61]. Rahimi et al. revealed protoscolicidal activity of the green synthesized silver NPs (Ag-NPs) and reported 90% mortality rate of protoscoleces using 0.15 mg/ml Ag-NP [62]. Nematollahi et al. compared protoscolicidal effects of Se-NPs and Ag-NPs and reported that the Se-NPs included higher protoscolicidal effects than those the Ag-NPs did [63]. Napooni et al. reported that gold NPs (Au-NPs) at 4 mg/ml concentrations killed 76% of the protoscoleces within 60 min [64]. More recently, Ezzatkhah et al. (2021) reported potent protoscolicidal effects of Copper-NPs, especially in combination with albendazole, which entirely eliminated the parasites after 10 − 20 min of exposure [65]. It has been verified that nanomaterials can interact with various living molecules and microbes because of their large surface-to-volume ratio and easier entry into the cells, compared to other particles. Therefore, nanomaterials can interrupt microbial pathogens, especially parasites [66].

Based on the several studies, the mean size of curcuminoid NEs is often less than 100 nm [67]. In the current study, the average particle size and zeta potential of the prepared CUR-NE included 60.4 ± 14.8 nm and − 16.3 ± 1.1 mV, respectively. Additionally, high stability of the present CUR-NEs was seen during 2 months of storage at room temperature. This can be associated to highly negative zeta potential of the present CUR-NEs. Highly positive and negative zeta potentials have been demonstrated in experiments to technically serve stabilities of microemulsions (MEs) and NEs because of their highly charged surfaces that resist aggregation of droplets [68]. Usually, conventional emulsions include low stabilities as shown by sedimentation of stored CUR at RT. Often, NEs lead to an improved physical stability [69]. However, CUR does not come to contact with water in the external phase because CUR is absorbed into the oily phase. Hence, NEs seem to provide inactive conditions for CUR. In NEs, CUR is actively protected from degradation [69].

In the current study, more detail and more clear observation of morphological changes of protoscoleces were observed using DIC microscopy [70]. Antibacterial mechanisms of CUR are well documented [71]. CUR uses multiple mechanisms to kill Candida albicans, including signaling alteration, cell wall integrity loss, metabolic shift, cell stress, DNA synthesis and repair, hyphal development, mitochondrial integrity and transcriptional and translational regulation. Of these mechanisms, CUR significantly affects genes that control cell wall integrity, because most of the genes of the pathway were downregulated [71]. Alterations in cell membrane permeability reveal changes in the physical state of the membrane or compromised cell wall integrity. These changes can result in leakages of proteinaceous constituents and other cell contents. However, the modes of action of CUR in parasitic diseases are not clearly understood and further studies are necessary to precisely investigate the exact action mechanisms of CUR on parasites, especially protoscoleces of CE.

Conclusion

This is the first report on in vitro effects of CUR-NEs, as protoscolicidal agents, on protoscoleces of E. granulosus sensu stricto. The results showed effective, promising protoscolicidal activities. Therefore, CUR-NEs are addressed as a novel protoscolicidal agents, which can be used as alternative natural medicine to kill the protoscoleces, owing to their low toxicity and significant inhibition potency. However, the use of CUR-NE therapeutics is still in its primary stage. Further studies are necessary to investigate the pharmacologic and pharmacokinetics of CUR-NEs.

Availability of data and materials

All data generated or analyzed during this study are included in this published article. The raw data are available from the corresponding author upon reasonable request.

References

  1. Eckert J, Thompson RC. Historical aspects of echinococcosis. Adv Parasitol. 2017;95:1–64.

    Article  CAS  PubMed  Google Scholar 

  2. WHO (World Health Organization). First WHO report on neglected tropical diseases: working to overcome the global impact of neglected tropical diseases. Geneva: WHO; 2010.

    Google Scholar 

  3. Higuita N, Iván A, Brunetti E, McCloskey C. Cystic echinococcosis. J Clin Microbiol. 2016;54:518–23. https://doi.org/10.1128/JCM.02420-15.

    Article  CAS  Google Scholar 

  4. Thompson RCA. Biology and systematics of Echinococcus. Adv Parasitol. 2017;95:65–109. https://doi.org/10.1016/bs.apar.2016.07.00.

    Article  CAS  PubMed  Google Scholar 

  5. Wen H, Vuitton L, Tuxun T, Li J, Vuitton DA, Zhang W, McManus DP. Echinococcosis: advances in the 21st century. Clin Microbiol Rev. 2019;32:e00075–18. https://doi.org/10.1128/CMR.00075-18.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Torgerson PR, Robertson LJ, Enemark HL, Foehr J, van der Giessen JWB, Kapel CMO, Klun I, Trevisan C. Source attribution of human echinococcosis: a systematic review and meta-analysis. PLoS Negl Trop Dis. 2020;14:e0008382. https://doi.org/10.1371/journal.pntd.0008382.

    Article  PubMed  PubMed Central  Google Scholar 

  7. World Health Organization. International classification of ultrasound images in cystic echinococcosis for application in clinical and field epidemiological settings. Acta Trop. 2003;85:253–61.

    Article  Google Scholar 

  8. Horton R. Albendazole in treatment of human cystic echinococcosis: 12 years of experience. Acta Trop. 1997;64:79–93.

    Article  CAS  PubMed  Google Scholar 

  9. Erzurumlu K, Hokelek M, Baris S, Sahin M, Birinci A, Amanvermez R, Tac K. Effect of albendazole sulfoxide solution on the scolices and the hepatobiliary system. Eur Surg Res. 1998;30:433–8.

    Article  CAS  PubMed  Google Scholar 

  10. Smego RA, Sebanego P. Treatment options for hepatic cystic echinococcosis. Int J Infect Dis. 2005;9:69–76.

    Article  PubMed  Google Scholar 

  11. Adas G, Arikan S, Kemik O, Oner A, Sahip N, Karatepe O. Use of albendazole sulfoxide, albendazole sulfone, and combined solutions as scolicidal agents on hydatid cysts (in vitro study). World J Gastroenterology. 2009;15:112.

    Article  CAS  Google Scholar 

  12. Sadjjadi SM, Ardehali S, Noman-Pour B, Kumar V, Izadpanah A. Diagnosis of cystic echinococcosis: ultrasound imaging or counter current immunoelectrophoresis? East Mediterr Health J. 2001;7:907–11.

    Article  CAS  PubMed  Google Scholar 

  13. Junghanss T, Da Silva AM, Horton J, Chiodini PL, Brunetti E. Clinical management of cystic echinococcosis: state of the art, problems, and perspectives. Am J Trop Med Hyg. 2008;79:301–11.

    Article  PubMed  Google Scholar 

  14. Aggarwal BB, Sung B. Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. Trends Pharmacol Sci. 2009;30(2):85–94.

    Article  CAS  PubMed  Google Scholar 

  15. García-Niño WR, Pedraza-Chaverrí J. Protective effect of curcumin against heavy metals-induced liver damage. Food Chem Toxicol. 2014;69:182–201.

    Article  PubMed  Google Scholar 

  16. Yallapu MM, Nagesh PK, Jaggi M, Chauhan SC. Therapeutic applications of curcumin nanoformulations. Aaps J. 2015;17(6):1341–56.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Bulboacă A, Bolboacă DS, Suci S. Protective effect of curcumin in fructose-induced metabolic syndrome and in streptozotocin-induced diabetes in rats. Iran J Basic Med Sci. 2016;19(6):585–93.

    PubMed  PubMed Central  Google Scholar 

  18. Bulboacă AE, Bolboacă SD, Stănescu IC, Sfrângeu CA, Bulboacă AC. Preemptive analgesic and antioxidative effect of curcumin for experimental migraine. Biomed Res Int. 2017;2017:4754701.

  19. Bulboacă AE, Bolboacă SD, Stănescu IC, Sfrângeu CA, Porfire A, Tefas L, Bulboacă AC. The effect of intravenous administration of liposomal curcumin in addition to sumatriptan treatment in an experimental migraine model in rats. Int J Nanomedicine. 2018;13:3093–103.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Moghadamtousi SZ, Kadir HA, Hassandarvish P, Tajik H, Abubakar S, Zandi K. (2014). A review on antibacterial, antiviral, and antifungal activity of curcumin. Biomed Res Int. 2014:186864.

  21. Aggarwal BB, Harikumar KB. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol. 2009;41(1):40–59.

    Article  CAS  PubMed  Google Scholar 

  22. Zhuangzhuang J, Bohan C, Yingliang W, Yue Y, He Z, Jiabao L, Longhuan P, Lunhao B. Curcumin exerts chondroprotective effects against osteoarthritis by promoting AMPK/PINK1/Parkin-mediated mitophagy. Biomed Pharmacother. 2022;151:113092. https://doi.org/10.1016/j.biopha.2022.113092.

    Article  CAS  Google Scholar 

  23. Feng T, Wei Y, Lee RJ, Zhao L. Liposomal curcumin and its application in cancer. Int J Nanomedicine. 2017;12:6027–44.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. de Moraes J. Natural products with antischistosomal activity. Future Med Chem. 2015;7(6):801–20.

    Article  PubMed  Google Scholar 

  25. Koide T, Nose M, Ogihara Y, Yabu Y, Ohta N. Leishmanicidal effect of curcumin in vitro. Biol Pharm Bull. 2002;25(1):131–3.

    Article  CAS  PubMed  Google Scholar 

  26. Das R, Roy A, Dutta N, Majumder HK. Reactive oxygen species and imbalance of calcium homeostasis contributes to curcumin induced programmed cell death in Leishmania donovani. Apoptosis. 2008;13(7):867–82.

    Article  CAS  PubMed  Google Scholar 

  27. Pérez-Arriaga L, Mendoza-Magaña ML, Cortés-Zárate R, Corona-Rivera A, Bobadilla-Morales L, Troyo-Sanromán R, Ramírez-Herrera MA. Cytotoxic effect of curcumin on Giardia lamblia trophozoites. Acta Trop. 2006;98(2):152–61.

    Article  PubMed  Google Scholar 

  28. Nose M, Koide T, Ogihara Y, Yabu Y, Ohta N. Trypanocidal effects of curcumin in vitro. Biol Pharm Bull. 1998;21(6):643–5.

    Article  CAS  PubMed  Google Scholar 

  29. Nagajyothi F, Zhao D, Weiss LM, Tanowitz HB. Curcumin treatment provides protection against Trypanosoma cruzi infection. Parasitol Res. 2012;110(6):2491–99.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Cui L, Miao J, Cui L. Cytotoxic effect of curcumin on malaria parasite Plasmodium falciparum: inhibition of histone acetylation and generation of reactive oxygen species. Antimicrob Agents Chemother. 2007;51(2):488–94.

    Article  CAS  PubMed  Google Scholar 

  31. Azami SJ, Teimouri A, Keshavarz H, Amani A, Esmaeili F, Hasanpour H, Elikaee S, Salehiniya H, Shojaee S. Curcumin nanoemulsion as a novel chemical for the treatment of acute and chronic toxoplasmosis in mice. Int J Nanomed. 2018;13:7363–74. https://doi.org/10.2147/IJN.S181896.

    Article  CAS  Google Scholar 

  32. Napooni S, Delavari M, Arbabi M, Barkheh H, Rasti S, Hooshyar H, Hosseinpour Mashkani M, S. Scolicidal Effects of Chitosan-Curcumin Nanoparticles on the Hydatid Cyst Protoscolices. Acta Parasitol. 2019;64(2):367–75. https://doi.org/10.2478/s11686-019-00054-8.

    Article  PubMed  Google Scholar 

  33. Firouzeh N, Eslaminejad T, Shafiei R, Faridi A, Fasihi Harandi M. Lethal in vitro effects of optimized chitosan nanoparticles against protoscoleces of Echinococcus granulosus. J Bioactive Compatible Polym. 2021;36(3):237–48. https://doi.org/10.1177/08839115211014219.

    Article  CAS  Google Scholar 

  34. Flora G, Gupta D, Tiwari A. Nanocurcumin: a promising therapeutic advancement over native curcumin. Crit Rev Ther Drug Carrier Syst. 2013;30(4):331–68.

    Article  CAS  PubMed  Google Scholar 

  35. Wang S, Su R, Nie SF, Sun M, Zhang J, Wu DY, Moustaid-Moussa N. Application of nanotechnology in improving bioavailability and bioactivity of diet-derived phytochemicals. J Nutr Biochem. 2014;25(4):363–76.

    Article  CAS  PubMed  Google Scholar 

  36. Sharifi S, Fathi N, Memar MY, Hosseiniyan Khatibi SM, Khalilov R, Negahdari R, Vahed Z, Maleki S, Dizaj S. Anti-microbial activity of curcumin nanoformulations: new trends and future perspectives. Phytother Res. 2020;34(8):1926–46. https://doi.org/10.1002/ptr.6658.

    Article  CAS  PubMed  Google Scholar 

  37. Gupta A, Eral HB, Hatton TA, Doyle PS. Nanoemulsions: formation, properties and applications. Soft Matter. 2016;12(11):2826–41.

    Article  CAS  PubMed  Google Scholar 

  38. Almalki E, Al-Shaebi EM, Al-Quarishy S, El-Matbouli M, Abdel-Baki. A.S. In vitro effectiveness of Curcuma longa and Zingiber officinale extracts on Echinococcus protoscoleces. Saudi J Biol Sci. 2017;24(1):90–4. https://doi.org/10.1016/j.sjbs.2016.05.007

  39. Kohansal MH, Nourian A, Rahimi MT, Daryani A, Spotin A, Ahmadpour E. Natural products applied against hydatid cyst protoscolices: a review of past to present. Acta Trop. 2017;176:385–94. https://doi.org/10.1016/j.actatropica.2017.09.013.

    Article  CAS  PubMed  Google Scholar 

  40. Mahmoudvand H, Pakravanan M, Aflatoonian MR, Khalaf AK, Niazi M, Mirbadie SR, Tavakoli Kareshk A, Khatami M. Efficacy and safety of Curcuma longa essential oil to inactivate hydatid cyst protoscoleces. BMC Complement Altern Med. 2019;19(1):187. https://doi.org/10.1186/s12906-019-2527-3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Sadjjadi SM, Zoharizadeh MR, Panjeshahin MR. In vitro screening of different Allium sativum extracts on hydatid cysts protoscoleces. J Invest Surg. 2008;21(6):318–22. https://doi.org/10.1080/08941930802348261.

    Article  PubMed  Google Scholar 

  42. Hosseini SV, Ghanbarzadeh K, Barzin J, Sadjjadi SM, Tanideh N, Mehrabani D. (2006). In vitro protoscolicidal effects of hypertonic glucose on protoscolices of hydatid cyst. Korean J Parasitol. 44(3) (2006) 239–242. https://doi.org/10.3347/kjp.2006.44.3.239

  43. Tabatabaei ZS, Dehshahri S, Taghi MM, Esfandiari F, Sadjjadi FS, Ebrahimipour M, Sadjjadi SM. In Vitro Study on Protoscolicidal Effect of Methanolic Extract of Allium hirtifolium on Protoscoleces of cystic echinococcosis. Infect Disord – Drug Targets. 2019;19(3):264–8. https://doi.org/10.2174/1871526518666180509130838.

    Article  CAS  PubMed  Google Scholar 

  44. Fletcher RH, Fletcher SW, Wagner EH. Clinical Epidemiology: The Essentials. 3rd ed. Baltimore: Williams and Wilkins; 1996.

  45. Lahlou M. The success of natural products in drug discovery. Pharmacol Pharm. 2013;4(3):17–31.

    Article  Google Scholar 

  46. Teimouri A, Haghi AM, Nateghpour M, Farivar L, Hanifian H, Mavi SA, Zare R. Antimalarial efficacy of low molecular weight chitosan against Plasmodium berghei infection in mice. J Vector Borne Dis. 2016;53(4):312–6. (PMID: 28035107).

    CAS  PubMed  Google Scholar 

  47. Teimouri A, Azami SJ, Keshavarz H, Esmaeili F, Alimi R, Mavi SA, Shojaee S. Anti-Toxoplasma activity of various molecular weights and concentrations of chitosan nanoparticles on tachyzoites of RH strain. Int J Nanomedicine. 2018;8(13):1341–51. https://doi.org/10.2147/IJN.S158736. PMID: 29563791; PMCID: PMC5849388.

    Article  Google Scholar 

  48. Yuan H, Ma Q, Ye L, Piao G. The traditional medicine and modern medicine from natural products. Molecules. 2016;21(5):559.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Jazani N, Ghasemnejad-Berenji H, Sadegpoor S. Antibacterial effects of iranian Mentha pulegium essential oil on isolates of Klebsiella sp. Pak J Biol Sci. 2009;12:183.

    Article  CAS  PubMed  Google Scholar 

  50. Oppenheimer A. Turmeric (curcumin) in biliary diseases. Lancet. 1937;229(5924):619–21.

    Article  Google Scholar 

  51. Vogel A, Pelletier J. Examen chimique de la racine de Curcuma. [Chemical review of tuemric root]. J Pharm. 1815;1:289–300. French.

    Google Scholar 

  52. Cowan MM. Plant products as antimicrobial agents. Clin Microbiol Rev. 1999;12(4):564–82.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Chainani-Wu N. (2003). Safety and anti-inflammatory activity of curcumin: A component of turmeric (Curcuma longa). J. Altern. Complement. Med. 9 (2003) 161–168.

  54. Ali BH, Marrif H, Noureldayem SA, Bakheit AO, Blunden G. Some Biological Properties of Curcumin: a review. Nat Prod Commun. 2006. https://doi.org/10.1177/1934578X0600100613.

    Article  Google Scholar 

  55. Bhawana RK, Basniwal HS, Buttar VK, Jain N. Curcumin nanoparticles: preparation, characterization, and antimicrobial study. J Agric Food Chem. 2011;59(5):2056–61.

    Article  CAS  PubMed  Google Scholar 

  56. Haddad M, Sauvain M, Deharo E. Curcuma as a parasiticidal agent: a review. Planta Med. 2011;77(6):672–8.

    Article  CAS  PubMed  Google Scholar 

  57. Lovelyn C, Attama AA. Current state of nanoemulsions in drug delivery. J Biomater Nanobiotechnol. 2011;2(5):626–39.

    Article  CAS  Google Scholar 

  58. Said D, Elsamad L, Gohar Y. Validity of silver, chitosan, and curcumin nanoparticles as anti-Giardia agents. Parasitol Res. 2012;111:545e554.

    Article  Google Scholar 

  59. Albalawi AE, Alanazi AD, Baharvand P, Sepahvand M, Mahmoudvand H. High potency of Organic and Inorganic Nanoparticles to treat cystic echinococcosis: an evidence-based review. Nanomaterials. 2020;10(12):2538. https://doi.org/10.3390/nano10122538.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Hamad SM, Shnawa BH, Jalil PJ, Ahmed MH. Assessment of the therapeutic efficacy of silver nanoparticles against secondary cystic echinococcosis in BALB/c mice. Surfaces. 2022;5:91–112. https://doi.org/10.3390/surfaces5010004.

    Article  CAS  Google Scholar 

  61. Mahmoudvand H, Fasihi Harandi M, Shakibaie M, Aflatoonian MR, ZiaAli N, Makki MS, Jahanbakhsh S. Scolicidal effects of biogenic selenium nanoparticles against protoscolices of hydatid cysts. Int J Surg. 2014;12(5):399–403. https://doi.org/10.1016/j.ijsu.2014.03.017.

    Article  PubMed  Google Scholar 

  62. Rahimi MT, Ahmadpour E, Rahimi EB, Spotin A, Kohansal Koshki MH, Alizadeh A, Honary S, Barabadi H, Mohammadi MA. Scolicidal activity of biosynthesized silver nanoparticles against Echinococcus granulosus protoscolices. Int J Surg. 2015;19:128–33.

    Article  PubMed  Google Scholar 

  63. Nematollahi A, Shahbazi P, Rafat A, Ghanbarlu M. Comparative survey on scolicidal efects of selenium and silver nanoparticles on protoscolices of hydatid cyst. Open Vet J. 2018;8:374–7.

    Article  PubMed  PubMed Central  Google Scholar 

  64. Napooni S, Arbabi M, Delavari M, Hooshyar H, Rasti S. Lethal effects of gold nanoparticles on protoscolices of hydatid cyst: in vitro study. Comparat Clin Pathol. 2019;28:143–50.

    Article  CAS  Google Scholar 

  65. Ezzatkhah F, Khalaf AK, Mahmoudvand H. Copper nanoparticles: biosynthesis, characterization, and protoscolicidal effects alone and combined with albendazole against hydatid cyst protoscoleces. Biomed Pharmacother. 2021;136:111257. https://doi.org/10.1016/j.biopha.2021.111257.

    Article  CAS  PubMed  Google Scholar 

  66. Schabes-Retchkiman PS, Canizal G, Herrera-Becerra R, et al. Biosynthesis and characterization of Ti/Ni bimetallic nanoparticles. Opt Mater. 2006;29:95–9.

    Article  CAS  Google Scholar 

  67. Lu PS, Inbaraj BS, Chen BH. Determination of oral bioavailability of curcuminoid dispersions and nanoemulsions prepared from Curcuma longa Linnaeus. J Sci Food Agric. 2018;98(1):51–63.

    Article  CAS  PubMed  Google Scholar 

  68. Park HJ, Kong M. Stability investigation of hyaluronic acid based nanoemulsion and its potential as transdermal carrier. Carbohydr Polym. 2011;83:303–1310.

    Google Scholar 

  69. Rachmawati H, Budiputra DK, Mauludin R. Curcumin nanoemulsion for transdermal application: formulation and evaluation. Drug Dev Ind Pharm. 2015;41(4):560–6.

    Article  CAS  PubMed  Google Scholar 

  70. Sadjjadi SF, Motamedi M, Mohammadzadeh T, Sadjjadi SM. (2019). Comparative morphologic and morphometric study on the developmental aspects of in vitro and in vivo reared Echinococcus granulosus sensu stricto using differential interference contrast (DIC)/Nomarski and phase contrast microscopy. Iranian Journal of Parasitology 14, no. 4 (2019): 510.

  71. Kumar A, Dhamgaye S, Maurya IK, Singh A, Sharma M, Prasad R. Curcumin targets cell wall integrity via calcineurin-mediated signaling in Candida albicans. Antimicrob Agents Chemother. 2014;58(1):167–75. https://doi.org/10.1128/AAC.01385-13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We would like to acknowledge all staff from the Helminthology laboratory, Shiraz University of Medical Sciences, Shiraz, Iran, for their useful collaboration.

Funding

This research was financially supported by the office of the Vice-chancellor for research at Shiraz University of Medical Sciences with grant No: 21829.

Author information

Authors and Affiliations

  1. Department of Parasitology and Mycology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

    Aref Teimouri, Mohammad Ghanimatdan, Mohammad Saleh Bahreini & Seyed Mahmoud Sadjjadi

  2. Department of Medical Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran

    Sanaz Jafarpour Azami & Saeedeh Hashemi Hafshejani

  3. Department of Epidemiology and Biostatistics, School of Health, Torbat Heydariyeh University of Medical Sciences, Torbat Heydariyeh, Iran

    Rasoul Alimi

Authors
  1. Aref Teimouri
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sanaz Jafarpour Azami
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Saeedeh Hashemi Hafshejani
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mohammad Ghanimatdan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Mohammad Saleh Bahreini
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Rasoul Alimi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Seyed Mahmoud Sadjjadi
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

AT and SMS conceived and designed the study. SJA and SHH involved in the synthesis and characterization of curcumin. AT, MG and MSB carried out the experiments. AT, and RA analyzed and interpreted data. AT prepared the original draft paper. AT and SMS reviewed and edited the final version of the manuscript. All authors have read and approved the final manuscript.

Corresponding author

Correspondence to Seyed Mahmoud Sadjjadi.

Ethics declarations

Conflict of interest

The authors declare that there are no conflicts of interest. All experiments were performed in accordance with relevant guidelines and regulations.

Ethical approval and consent

This study was carried out based on the Declaration of Helsinki and approved by the Research Ethics Committee of Shiraz University of Medical Sciences (ethical code: IR.SUMS.MED.REC.1399.425).

Consent for publication

Not applicable.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Teimouri, A., Jafarpour Azami, S., Hashemi Hafshejani, S. et al. Protoscolicidal effects of curcumin nanoemulsion against protoscoleces of Echinococcus granulosus. BMC Complement Med Ther 23, 124 (2023). https://doi.org/10.1186/s12906-023-03927-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12906-023-03927-8

Keywords

BMC Complementary Medicine and Therapies

ISSN: 2662-7671

Contact us